Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Experimental Melanomas”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Very early researchStudy completedNCT00972933
What this trial is testing

Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma

Who this might be right for
Melanoma
Diwakar Davar 59
Testing effectiveness (Phase 2)WithdrawnNCT05572463
What this trial is testing

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Who this might be right for
Unresectable Cutaneous MelanomaMetastatic Cutaneous Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Testing effectiveness (Phase 2)Study completedNCT02658890
What this trial is testing

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced CancerMelanomaNon-Small Cell Lung Cancer
Bristol-Myers Squibb 627
Testing effectiveness (Phase 2)Study completedNCT00513604
What this trial is testing

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental+1 more
National Cancer Institute (NCI) 158
Early research (Phase 1)Study completedNCT01295931
What this trial is testing

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT04305041
What this trial is testing

Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)Study completedNCT04700072
What this trial is testing

Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)Study completedNCT02320058
What this trial is testing

An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself

Who this might be right for
Melanoma
Bristol-Myers Squibb 119
Early research (Phase 1)Ended earlyNCT02723006
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma

Who this might be right for
Melanoma
Millennium Pharmaceuticals, Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305054
What this trial is testing

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 315
Testing effectiveness (Phase 2)Study completedNCT04303169
What this trial is testing

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 146
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Post-approval studies (Phase 4)Study completedNCT04320316
What this trial is testing

A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)

Who this might be right for
Epidermal Nevus Syndrome
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060432
What this trial is testing

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

Who this might be right for
Advanced CancerLung CancerHead and Neck Cancer+1 more
iTeos Belgium SA 153
Early research (Phase 1)Study completedNCT04165967
What this trial is testing

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

Who this might be right for
Advanced Melanoma
University Hospital, Basel, Switzerland 9
Testing effectiveness (Phase 2)Study completedNCT00044356
What this trial is testing

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaMalignant Melanoma+1 more
Vical 133
Early research (Phase 1)Ended earlyNCT04625205
What this trial is testing

A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
BioNTech US Inc. 22
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 980
Early research (Phase 1)Ended earlyNCT02711345
What this trial is testing

A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.

Who this might be right for
Ovarian NeoplasmsNon-Small-Cell Lung CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 65
Load More Results